Saccharomyces boulardii in childhood (original) (raw)
Andersson H, Asp NG, Bruce A et al (2001) Health effects of probiotics and prebiotics. A literature review on human studies. Scand J Nutr 45:58–95 Google Scholar
Barbut F, Meynard JL, Guiguet M et al (1997) _Clostridium difficile_-associated diarrhea in HIV infected patients: epidemiology and risk factors. J Acq Immun Def Synd 16:176–181 CAS Google Scholar
Bartlett JG, Chang TW, Gurwith M et al (1978) Antibiotic-associated pseudomembranous colitis due to toxin producing Clostridia. N Engl J Med 298:531–534 PubMedCAS Google Scholar
Bartlett JG (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346:334–339 ArticlePubMed Google Scholar
Bassetti S, Frei R, Zimmerli W (1998) Fungemia with Saccharomyces cerevisiae after treatment with S. boulardii. Am J Med 105:71–72 ArticlePubMedCAS Google Scholar
Baumgart D (2007) The probiotic yeast Saccharomyces boulardii inhibits DC-induced activation of naïve T-cells. Gastroenterology 135(4):A–559 (sup 1) Google Scholar
Benhamou PH, Berlier P, Danjou G et al (1999) Antibiotic-associated diarrhoea in children: a computer monitored double-blind outpatients trial comparing a protective and a probiotic agent. Med Chir Dig 28:163–168 Google Scholar
Bernet MF, Brassart D, Neeser JR et al (1994) Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35:483–489 ArticlePubMedCAS Google Scholar
Bhatia SJ, Kochar N, Abraham P et al (1989) Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 27:2328–2330 PubMedCAS Google Scholar
Billoo AG, Memon MA, Khaskheli SA, Murtaza G, Iqbal K, Saeed Shekhani M, Siddiqi AQ (2006) Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol 12:4557–4560 PubMedCAS Google Scholar
Bléhaut H, Massot J, Elmer GW et al (1989) Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos 10:353–364 ArticlePubMed Google Scholar
Breves G, Faul K, Schröder B et al (2000) Application of the colon-stimulation technique for studying the effects of Saccharomyes boulardii on basic parameters of porcine cecal microbial metabolism disturbed by Clindamycin. Digestion 61:193–200 ArticlePubMedCAS Google Scholar
Brunser O (2009) Coincubation of Saccharomyces boulardii with Helicobacter pylori. A Morphological Study (in press)
Burkhardt O, Köhnlein T, Pletz M et al (2005) Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand J Infect Dis 37:69–72 ArticlePubMedCAS Google Scholar
Buts JP, Bernasconi P, Vaerman JP et al (1990) Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 35:251–256 ArticlePubMedCAS Google Scholar
Buts JP, Bernasconi P, Van Craynest MP et al (1986) Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res 20:192–196 ArticlePubMedCAS Google Scholar
Buts JP, Corthier G, Delmee M (1993) Saccharomyces boulardii for _Clostridium difficile_-associated enteropathies in infants. J Pediatr Gastroenterol Nutr 16:419–425 PubMedCAS Google Scholar
Buts JP, De Keyser N, De Raedemaeker L (1994) Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatr Res 36:522–527 ArticlePubMedCAS Google Scholar
Buts JP, Duranton B, De Keyser N et al (1998) Premature stimulation of rat sucrase-isomaltase (SI) by exogenous insulin and the analog B-Asp10 is regulated by a receptor-mediated signal triggering SI gene transcription. Pediatr Res 43:585–591 ArticlePubMedCAS Google Scholar
Buts JP, De Keyser N, Marandi S et al (1999) Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats. Gut 45:89–96 PubMedCAS Google Scholar
Buts JP, De Keyser N, Stilmant C et al (2002) Saccharomyces boulardii enhances N-terminal peptide hydrolysis in suckling rat small intestine by endoluminal release of a zinc-binding metalloprotease. Pediatr Res 51:528–534 ArticlePubMedCAS Google Scholar
Buts JP, Dekeyser N, Stilmant C et al (2006) Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr Res 60:24–29 ArticlePubMedCAS Google Scholar
Canani RB, Cirillo P, Terrin GA et al (2007) Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 335:340–347 ArticlePubMed Google Scholar
Castagliuolo I, LaMont JT, Nikulasson ST et al (1996) Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun 12:5225–5232 Google Scholar
Castagliuolo I, Riegler MF, Valenick L et al (1999) Saccharomyces boulardii protease mediates Clostridium difficile toxin A and B effects in human colonic mucosa. Infect Immun 67:302–307 PubMedCAS Google Scholar
Castaneda C, Garcia E, Santa Cruz M, Fernandez M, Monterrey P (1995) Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases due to giardiasis. Rev Mex Pueric Pediatr 2:12–16 Google Scholar
Cetina-Sauri G, Busto GS (1994) Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Ann Ped 6:397–400 Google Scholar
Cindoruk M, Erkan G, Karakan T et al (2007) Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter 12:309–316 ArticlePubMed Google Scholar
Czerucka D, Dahan S, Mograbi B et al (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic _Escherichia coli_-infected T84 cells. Infect Immun 68:5998–6004 ArticlePubMedCAS Google Scholar
Czerucka D, Piche T, Rampal P (2007) Review article: yeast as probiotics—Saccharomyces boulardii. Aliment Pharmacol Ther 26:767–778 PubMedCAS Google Scholar
Czerucka D, Rampal P (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4:733–739 ArticlePubMed Google Scholar
Czerucka D, Roux I, Rampal P (1994) Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′, 5′-cyclic monophosphate induction in intestinal cells. Gastroenterology 106:65–72 PubMedCAS Google Scholar
Dahan S, Dalmasso G, Imbert V et al (2003) Saccharomyces boulardii interfers with enterohemorragic _Escherichia coli_-induced signaling pathways in T84 cells. Infect Immun 71:766–773 ArticlePubMedCAS Google Scholar
Dalmasso G, Cottrez F, Imbert V et al (2006) Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology 131:1812–1825 ArticlePubMedCAS Google Scholar
Dalmasso G, Loubat A, Dahan S et al (2006) Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells. Res Microbiol 157:456–465 ArticlePubMedCAS Google Scholar
de Llanos R, Querol A, Pemán J et al (2006) Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int J Food Microbiol 110:286–289 ArticlePubMedCAS Google Scholar
Desreumeaux P, Rousseaux C (2006) Influence of the intestinal microflora on host immunity in inflammatory bowel disease. In G. Microflora Ed. John Libbey Eurotext
Duman DG, Bor S, Ozütemiz O et al (2005) Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 17:1357–1361 ArticlePubMed Google Scholar
Elmer GW, Corthier G (1991) Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice. Can J Microbiol 37:315–317 PubMedCAS Google Scholar
Elmer GW, McFarland LV, Surawicz CM et al (1999) Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther 13:1663–1668 ArticlePubMedCAS Google Scholar
Elmer GW, Moyer KA, Vega R et al (1995) Evaluation of Saccharomyces boulardii for patients with HIV-related chronic diarrhoea and in healthy volunteers receiving antifungals. Microecol and Ther 25:23–31 Google Scholar
Elstner CL, Lindsay AN, Book LS et al (1983) Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children. Pediatr Inf Dis 2:364–366 CAS Google Scholar
Erdeve O, Tiras U, Dallar Y (2004) The probiotic effect of Saccharomyces boulardii in a pediatric age group. J Trop Pediatr 50:234–236 ArticlePubMed Google Scholar
Fietto JLR, Araújo RS, Valadão FN et al (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50:615–621 ArticlePubMedCAS Google Scholar
Gaon D, Garcia H, Winter L et al (2003) Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 63:293–298 Google Scholar
Gedek BR (1999) Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42:261–264 ArticlePubMedCAS Google Scholar
Geyik MF, Aldemir M, Hosoglu S et al (2006) The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice. Ann R Coll Surg Engl 88:176–180 ArticlePubMed Google Scholar
Girard P, Pansart Y, Lorette I et al (2003) Dose–response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats. Dig Dis Sci 48:770–774 ArticlePubMedCAS Google Scholar
Goldman CG, Barrado DA, Balcarce N et al (2006) Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 22:984–988 ArticlePubMed Google Scholar
Gotteland M, Poliak L, Cruchet S et al (2005) Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Paediatr 94:1747–1751 ArticlePubMed Google Scholar
Graf C, Gavazzi G (2007) Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation. J Infect 54:310–311 ArticlePubMedCAS Google Scholar
Guarino A, Albano F, Ashkenazi S et al (2008) The ESPGHAN/ESPID Guidelines for the Management of Acute Gastroenteritis in Children in Europe. J Pediatr Gastroenterol Nutr 46:S81–S122 ArticlePubMed Google Scholar
Hafeez A, Tariq P, Ali S et al (2002) The efficacy of Saccharomyces boulardii in the treatment of acute watery diarrhea in children: a multicentre randomized controlled trial. J Coll Phys Surg Pakist 12:432–434 Google Scholar
Hennequin C, Kauffman-Lacroix C, Jobert A et al (2000) Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Diseases 19:16–20 ArticleCAS Google Scholar
Hennequin C, Thierry A, Richard GF et al (2001) Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J Clin Microbiol 39:551–559 ArticlePubMedCAS Google Scholar
Herek O, Kara IG, Kaleli I (2004) Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury. Surg Today 34:256–260 ArticlePubMedCAS Google Scholar
Htwe K, Yee KS, Tin M, Vandenplas Y (2008) Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study. Am J Trop Med Hyg 78:214–216 PubMed Google Scholar
Jawhara S, Poulain D (2007) Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med Mycol 45:691–700 ArticlePubMedCAS Google Scholar
Klein SM, Elmer GW, McFarland LV et al (1993) Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers. Pharm Res 10:1615–1619 ArticlePubMedCAS Google Scholar
Kotowska M, Albrecht P, Szajewska H (2005) Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 21:583–590 ArticlePubMedCAS Google Scholar
Kurugol Z, Koturoglu G (2005) Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 94:44–47 ArticlePubMedCAS Google Scholar
Lionetti E, Miniello VL, Castellaneta SP et al (2006) Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 24:1461–1468 ArticlePubMedCAS Google Scholar
Luyer MD, Buurman WA, Hadfoune M et al (2005) Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 73:3686–3692 ArticlePubMedCAS Google Scholar
Mathur S, Singh R (2005) Antibiotic resistance in food lactic acid bacteria—a review. Int J Food Microbiol 105:281–295 ArticlePubMedCAS Google Scholar
McFarland LV, Surawicz CM, Stamm WE (1990) Risk factors for Clostridium difficile carriage and _C. difficile_-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 162:678–684 PubMedCAS Google Scholar
McFarland LV (1998) Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 16:292–307 ArticlePubMedCAS Google Scholar
Mumy KL, Chen X, Kelly CP et al (2008) Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am J Physiol Gastrointest Liver Physiol 294:G599–G609 ArticlePubMedCAS Google Scholar
Muñoz P, Bouza E, Cuenca-Estrella M et al (2005) Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 40:1625–1634 ArticlePubMed Google Scholar
Piechno S, Seguin P, Gangneux JP (2007) Saccharomyces boulardii fungal sepsis: beware of the yeast. Can J Anaesth 54:245–246 ArticlePubMed Google Scholar
Pothoulakis C, Kelly CP, Joshi MA et al (1993) Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 104:1108–1115 PubMedCAS Google Scholar
Riedel BD, Ghishan FK (1996) Acute diarrhea. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB (eds) Pediatric gastrointestinal disease, 2nd edn. Mosby-Year Book Inc., St. Louis, pp 251–262 Google Scholar
Rigothier MC, Maccario J, Vuong PN et al (1990) Effects of Saccharomyces boulardii yeast on trophozoites of Entamoeba histolytica in vitro and in cecal amebiasis in young rats. Ann Parasitol Hum Comp 65:51–60 PubMedCAS Google Scholar
Rijnders BJA, Van Wijngaerden E, Verwaest C et al (2000) Saccharomyces fungemia complicating S. boulardii treatment in a non-immunocompromised host. Intensive Care Med 26:825 ArticlePubMedCAS Google Scholar
Rodrigues ACP, Nardi RM, Bambirra EA et al (1996) Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri conventional and gnotobiotic mice. J Appl Bacteriol 91:251–256 Google Scholar
Schneider SM, Girard-Pipau F, Filippi J et al (2005) Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol 11:6165–6169 PubMedCAS Google Scholar
Sougioultzis S, Simeonidis S, Bhaskar KR et al (2006) Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343:69–76 ArticlePubMedCAS Google Scholar
Sykora J, Valeckova K, Amlerova J et al (2005) Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 39:692–698 ArticlePubMedCAS Google Scholar
Szajewska H, Setty M, Mrukowicz J et al (2006) Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr 42:454–475 ArticlePubMed Google Scholar
Szajewska H, Skórka A, Dylag M (2007) Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25:257–264 PubMedCAS Google Scholar
Temmerman R, Pot B, Huys G et al (2003) Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 81:1–10 ArticlePubMedCAS Google Scholar
Tong JL, Ran ZH, Shen J et al (2007) Meta-analysis: the effect of supplementation with probiotics on eradication rates and side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 25:155–168 ArticlePubMedCAS Google Scholar
Turck D, Bernet JP, Marx J et al (2003) Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr 37:22–26 ArticlePubMedCAS Google Scholar
Vandenplas Y, Salvatore S, Vieira M et al (2007) Probiotics in infectious diarrhoea in children: are they indicated? Eur J Pediatr 166:1211–1218 ArticlePubMedCAS Google Scholar
Villarruel G, Rubio DM, Lopez F et al (2007) Saccharomyces boulardii in acute childhood diarrhea: a randomized controlled study. Acta Paediatr 96:538–541 ArticlePubMed Google Scholar
WHO (2003) The treatment of diarrhoea. A manual for physicians and other senior health workers. WHO/CAH/03.7 10/03
WHO (1995) The treatment of diarrhea. A manual for physicians and other senior health workers; WHO/CDR/95.3. Geneva, World Health Organization
Wiström J, Norrby SR, Myhre EB et al (2001) Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47:43–50 ArticlePubMed Google Scholar
Wu X, Vallance BA, Boyer L et al (2008) Saccharomyces boulardii ameliorates _Citrobacter rodentium_-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 294:G295–G306 ArticlePubMedCAS Google Scholar
Zunic P, Lacotte J, Pegoix M et al (1991) S. boulardii fungemia. Apropos of a case. Therapie 46:498–499 PubMedCAS Google Scholar